On Nov. 26, 2018, Kramer Levin client Ebbu Inc., a leader in hemp research, announced that it has closed the deal transferring its IP, R&D and other assets to Canopy Growth Corp., a global diversified cannabis and hemp company listed on the TSX and NYSE. Canopy paid 6,221,210 common shares and CDN $25 million in cash for the assets, with up to an additional CDN$100 million upon achievement of scientific related milestones.